Strand Therapeutics
Parth Solanki currently holds the position of Associate Scientist II at Strand Therapeutics, where employment commenced in March 2022, after previously serving as Associate Scientist I. Parth gained valuable experience as an intern at AstraZeneca from July 2021 to December 2021. Parth holds a Master's degree in Pharmaceutical Sciences from the University of Maryland, Baltimore, and a Bachelor of Pharmacy (BPharm) from the Institute of Pharmacy at Nirma University, completed in 2019.
This person is not in any teams
Strand Therapeutics
3 followers
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics.